Pharmicell Co., Ltd. (KRX:005690)
South Korea · Delayed Price · Currency is KRW 17,150
-550 (-3.11%)
Feb 26, 2026, 9:40 AM KST
Pharmicell Market Cap
Pharmicell has a market cap or net worth of 1.06 trillion as of February 25, 2026. Its market cap has increased by 94.93% in one year.
Market Cap
1.06T
Enterprise Value
n/a
Revenue
23.94B
Ranking
n/a
PE Ratio
n/a
Stock Price
17,150.00
Market Cap Chart
Since August 29, 1995, Pharmicell's market cap has increased from 40.96B to 1.06T, an increase of 2,492.95%. That is a compound annual growth rate of 11.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 24, 2026 | 1.09T | 24.85% |
| Dec 30, 2025 | 871.86B | 75.48% |
| Dec 30, 2024 | 496.83B | 36.41% |
| Dec 28, 2023 | 364.22B | -46.28% |
| Dec 29, 2022 | 678.05B | -13.33% |
| Dec 30, 2021 | 782.30B | -24.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orum Therapeutics | 2.33T |
| Chabiotech | 1.95T |
| GI Innovation | 933.82B |
| Medy-Tox | 928.01B |
| Onconic Therapeutics | 847.93B |
| MEDIPOST | 838.39B |
| Green Cross Holdings | 739.59B |
| Proteina | 737.32B |